475
Views
14
CrossRef citations to date
0
Altmetric
Original Articles

Methadone Maintenance Therapy and HIV Counseling and Testing are Associated with Lower frequency of Risky Behaviors Among Injection Drug Users in China

, , , , , , , & show all

REFERENCES

  • Asher, A. K, Hahn, J. A, Couture, M. C , Maher, K, & Page, K. (2013). People who inject drugs, HIV risk, and HIV testing uptake in sub-Saharan Africa. J Assoc Nurses AIDS Care, 24(6), e35–44.
  • Bao, Y. G., & Zhang, Y. H. (2007). Risk factors on heroin lapse of methadone maintenance treatment outpatients. Practical Preventive Medicine, 14(6), 1923–1925.
  • Branson, B. M., Handsfield, H. H., Lampe, M. A., Janssen, R. S., Taylor, AW, Lyss, SB, & Clark, JE.(2006). Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep, 55(RR-14), 1–17; quiz CE11–14.
  • Bruneau, J, Daniel, M, Abrahamowicz, M, Zang, G, Lamothe, F, & Vincelette, J. (2011). Trends in human immunodeficiency virus incidence and risk behavior among injection drug users in montreal, Canada: A 16-year longitudinal study. Am J Epidemiol, 173(9), 1049–1058.
  • Carrieri, M. P., Moatti, J. P., Vlahov, D., Obadia, Y., Reynaud-Maurupt, C., & Chesney, M. (1999). Access to antiretroviral treatment among French HIV infected injection drug users: The influence of continued drug use. MANIF 2000 Study Group. J Epidemiol Community Health, 53(1), 4–8.
  • Chen, XS, Gong, XD, Liang, GJ, & Zhang, GC. (2000). Epidemiologic trends of sexually transmitted diseases in China. Sex Transm Dis, 27(3), 138–142.
  • Chen, KL, Hao, C, Yuan, YH, Xie, LZ, Wu, J, Xia, Y, … Qin, G. (2006). Qualitative study of factors contributed to retention in a community-based methadone maintenance treatment among heroin users. Chin J Drug Depend, 12(6), 315–319.
  • China National Narcotics Control Committee. (2011). Annual Report on Drug Control in China. Beijing.
  • Chu, T. X, & Levy, J. A. (2005). Injection drug use and HIV/AIDS transmission in China. Cell Res, 15(11–12), 865–869.
  • Cohen, MS, Chen, YQ, McCauley, M, Gamble, T, Hosseinipour, MC, Kumarasamy, N, … Pilotto, J. H.. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. The New England journal of medicine, 365(6), 493–505.
  • Cohen, M. S., Ping, G., & Fox, K.. (2000). Sexually transmitted diseases in the People's Republic of China in Y2K: Back to the future. Sex Transm Dis, 27, 143–145.
  • Downing, M, Knight, K, Reiss, TH, Vernon, K, Mulia, N, Ferreboeuf, M, … Vu, C. (2001). Drug users talk about HIV testing: Motivating and deterring factors. AIDS Care, 13(5), 561–577.
  • Ford, K., Wirawan, D. N., Sumantera, G. M., Sawitri, A. A., & Stahre, M. (2004). Voluntary HIV testing, disclosure, and stigma among injection drug users in Bali, Indonesia. AIDS Educ Prev, 16(6), 487–498.
  • Gao, Q, Cheng, H, & Ding, L. (2008). Characteristics of methadone maintenance treatment patients’ social network and status of sustainment ACTA UNIVERSITIS MEDICINALIS NANJING(Social Science), 32(3), 230–233.
  • Gong, X., Wang, Q., & Liang, G. (2001). Epidemiological trends of sexually transmitted diseases in China. Chin J STD AIDS Prev Control, 7(suppl), 46–51.
  • Gowing, L., Farrell, M., Bornemann, R., Sullivan, L., & Ali, R. (2008). Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev 16(2), CD004145.
  • Gowing, L., Farrell, M. F., Bornemann, R., Sullivan, L. E., Ali, R. (2011). Oral substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev (8), CD004145.
  • Hao, C., Wu, J., Ruan, Y., Yao, M., Yang, X., Li, L., … Song l. (2007). Factors associated with retention in a community-based methadone maintenance treatment among heroin addicts. Chin J Prev Med, 41(4), 250–253.
  • Jia, Y., Lu, F., Sun, X., & Vermund, S. H. (2007). Sources of data for improved surveillance of HIV/AIDS in China. Southeast Asian J Trop Med Public Health, 38(6), 1041–1052.
  • Jia, Y., Lu, F., Zeng, G., Sun, X., Xiao, Y., Lu, L., … Li, C. (2008). Predictors of HIV infection and prevalence for syphilis infection among injection drug users in China: Community-based surveys along major drug trafficking routes. Harm Reduct J, 5, 29.
  • Jia, Y., Sun, J., Fan, L., Song, D., Tian, S., Yang, Y., … Zhang, S. (2008) Estimates of HIV prevalence in a highly endemic area of China: Dehong Prefecture, Yunnan Province. Int J Epidemiol, 37(6), 1287–1296.
  • Liu, J. B.. (2007). Cox regression analysis of retention time and factors of methadone maintenance treatment Chin J AIDS STD, 13(2), 160–161.
  • Liu J. B., Zhang, L. L., Lai, W. H., Feng, L., Zeng, Y. L., Liu, L., … Xiao, Y. (2009). Sharing of needles and paraphernalia injection in new and long-term injection drug users in Sichuan, China. Zhonghua Liu Xing Bing Xue Za Zhi, 30(7), 656–662.
  • MacArthur, G. J., Minozzi, S., Martin, N., Vickerman, P., Deren, S., Bruneau, J., … Hickman M. (2012). Opiate substitution treatment and HIV transmission in people who inject drugs: Systematic review and meta-analysis. BMJ, 345, e5945.
  • Mao, W., Zhang, L., Xiao, Y., Jiang, B., Zhu, J., Ma, W., … Jia, Y. (2010). Barriers and facilitators to voluntary HIV counseling and testing among injection drug users and their attitudes toward the peer opinion leader-led HIV testing through diffusion of positive AIDS care messages. Journal of Shandong University (Medical Science Edition), 48(1), 146–150.
  • Marks, G., Crepaz, N., Senterfitt, J. W., & Janssen, R. S. (2005). Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: Implications for HIV prevention programs. J Acquir Immune Defic Syndr, 39(4), 446–453.
  • Metzger, D. S., Woody, G. E., McLellan, A. T., O'Brien, C. P., Druley, P., Navaline, H., … Abrutyn E. (1993). Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: An 18-month prospective follow-up. J Acquir Immune Defic Syndr, 6(9), 1049–1056.
  • Ministry of Health of China. (2006). Work Plan of Community Maintenance Treatment for Opioid Addicts.
  • Moatti, J. P., Carrieri, M. P., Spire, B., Gastaut, J. A., Cassuto, J. P., & Moreau J. (2000). Adherence to HAART in French HIV-infected injecting drug users: The contribution of buprenorphine drug maintenance treatment. The Manif 2000 study group. AIDS, 14(2), 151–155.
  • Montaner, J. S., Lima, V. D., Barrios, R., Yip, B., Wood, E., Kerr, T., , … Daly, P. (2010). Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: A population-based study. Lancet, 376(9740), 532–539.
  • Moss, A. R., Vranizan, K., Gorter, R., Bacchetti, P., Watters, J., & Osmond, D.. (1994). HIV seroconversion in intravenous drug users in San Francisco, 1985–1990. AIDS, 8(2), 223–231.
  • National Working Group on Community-based Methadone Maintenance Treatment for Opium Dependents. (2010). Report on Implementation of Community-based Methadone Maintenance Treatment. Guiyang: National Conference on Experience in Community-based Methadone Maintenance Treatment for Opium Dependents. .
  • Palepu, A., Tyndall, M. W., Joy, R., Kerr, T., Wood, E., Press, N., … Montaner, J. S. (2006). Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: The role of methadone maintenance therapy. Drug Alcohol Depend, 84(2), 188–194.
  • Rhodes, T., Ball, A., Stimson, G. V., Kobyshcha, Y., Fitch, C., Pokrovsky, V., … Andrushchak L. (1999). HIV infection associated with drug injecting in the newly independent states, eastern Europe: The social and economic context of epidemics. Addiction, 94(9), 1323–1336.
  • Serpelloni, G., Carrieri, M. P., Rezza, G., Morganti, S., Gomma, M., & Binkin N. (1994). Methadone treatment as a determinant of HIV risk reduction among injecting drug users: A nested case-control study. AIDS Care, 6(2), 215–220.
  • Shi, S., Huang, Y. S., & Li X. (2008). Correlation factors influencing the effect of methadone maintenance treatment. Chin J Drug Depend, 17(1), 56–60.
  • Sichuna Provincial CDC. (2009). HIV/AIDS Surveillance Report. Chengdu: Institute for AIDS/STD Control and Prevention.
  • Spire, B., Lucas, G. M., & Carrieri, M. P. (2007). Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST). Int J Drug Policy, 18(4), 262–270.
  • State Council of P.R. of China. (2012). China's Action Plan for Reducing and Preventing the Spread of HIV/AIDS (2011–2015).
  • Strathdee, S. A., Hallett, T. B., Bobrova, N., Rhodes, T., Booth, R., Abdool, R., & Hankins, CA. (2010). HIV and risk environment for injecting drug users: The past, present, and future. Lancet, 376(9737), 268–284.
  • Sullivan, S. G., & Wu, Z. (2007). Rapid scale up of harm reduction in China. Int J Drug Policy, 18(2), 118–128.
  • Vermund, S. H., & Wilson, C. M. (2002). Barriers to HIV testing–where next? Lancet, 360(9341), 1186–1187.
  • Wang, J, Li, F, Mo, LR, Li, L, Guan, Y, Hao, C, … Ruan, Y. (2007). Factors associated with retention in a community-based methadone maintenance treatment among drug users in Urumqi,Xinjiang Uigur Autonomous Region. Chin J Epidemiol, 28(1), 37–41.
  • Williams, A. B., McNelly, E. A., Williams, A. E., & D'Aquila, R. T. (1992). Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug users. AIDS Care, 4(1), 35–41.
  • Wu, Z., Luo, W., Sullivan, S. G., Rou, K., Lin, P., Liu, W., & Ming Z. (2007). Evaluation of a needle social marketing strategy to control HIV among injecting drug users in China. AIDS, 21 Suppl 8, S115–122.
  • Wu, Z., Sun, X., Sullivan, S. G., & Detels, R. (2006). Public health. HIV testing in China. Science (New York, NY, 312(5779), 1475–1476.
  • Wu, Z., Sullivan, S. G., Wang, Y., Rotheram-Borus, M. J., & Detels, R. (2007). Evolution of China's response to HIV/AIDS. Lancet, 369(9562), 679–690.
  • Zhang, L., Gray, R. T., & Wilson, D. P. Modelling the epidemiological impact of scaling up HIV testing and antiretroviral treatment in China. Sexual health, 9(3), 261–271.
  • Zhang, L., Li, J., Lai, W., Feng, L., Zeng, Y., Liu, L., … Wu, P. (2010). Prevalence and correlates of needle-sharing among new and long-term injection drug users in southwest China. Subst Use Misuse, 45(14), 2503–2523.
  • Zhang, L., Li, J., Lai, W., Feng, L., Zeng, Y., Liu, L., … Wu, P. (2011). Prevalence and correlates of needle-sharing among new and long-term injection drug users in southwest China. Subst Use Misuse, 45(14), 2503–2523.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.